ClinicalTrials.Veeva

Menu

Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer

I

Institute of Cancer Research, United Kingdom

Status

Completed

Conditions

Cancer

Treatments

Procedure: Magnetic Resonance Imaging using an endovaginal receiver coil

Study type

Observational

Funder types

Other

Identifiers

NCT01937533
13/EE/0198 CCR3938

Details and patient eligibility

About

This study aims to develop the technique of Diffusion-Weighted Magnetic Resonance Imaging(DW-MRI)for the assessment of stage 1 cervical cancers. An endovaginal receiver coil has been designed and developed at the Institute of Cancer Research and Royal Marsden NHS Foundation Trust for use at high field strengths(3T). This will be used to evaluate if DW-MRI at 3T can be used to differentiate different histological characteristics within whole tumours and so determine if the technique could be of prognostic value.

The study hypothesis is that this technique will be able to differentiate tumours with histological features known to be associated with poor prognosis (tumour type, grade and lymphovascular space invasion).

Enrollment

236 patients

Sex

Female

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients with presumed early stage cervical cancer being considered for curative surgery

Exclusion criteria

  • Ferromagnetic metal implants
  • claustrophobia (MRI incompatibility)

Trial design

236 participants in 1 patient group

Cervical Cancer
Description:
Patients with presumed early cervical cancer being considered for curative surgery
Treatment:
Procedure: Magnetic Resonance Imaging using an endovaginal receiver coil

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems